1 articles with this tag
<p>Aignostics has raised $34 million in a Series B round to expand product offerings, grow its U.S. presence, and co-develop foundation models for pathology with Mayo Clinic.</p> <p>The funding, led by ATHOS with participation from Mayo Clinic and other investors, brings Aignostics' total raised to over $55 million.</p> <p>The company plans to launch scalable AI solutions for tumor profiling and biomarker analysis, leveraging its recent successes, including the release of its first foundation model, RudolfV.</p>
